Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
319460-85-0
Purity
95%
Axitinib is an oral VEGFR and kinase inhibitor used for the treatment of advanced renal cell carcinoma after failure of one prior systemic therapy.
Properties
Name
Axitinib
Smiles
CNC(=O)C=1C=CC=CC1SC=2C=CC=3C(/C=C/C=4C=CC=CN4)=NNC3C2
Targets
Please log in to see this information
Sold for research purposes under agreement from Pfizer Inc.
SDS
(E)-axitinib | AG-013736 | Inlyta | axitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
(E)-axitinib | AG-013736 | Inlyta | axitinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:319460-85-0
0
CAS:
0